Molecular screening

OTHER3 trials

Sponsors

Fondazione del Piemonte per l'Oncologia, Timser SAPI de CV

Conditions

AGUSASC-USAtypical Glandular Cells of Uncertain SignificanceAtypical Squamous Cell of Undetermined SignificanceCIN 1CIN 2CIN 3Cervical Cancer

Phase 2

Rechallenge With Panitumumab Driven by RAS Dynamic of Resistance

CompletedNCT03227926

Fondazione del Piemonte per l'OncologiaColorectal Cancer

Start: 2017-10-11End: 2021-12-31Updated: 2022-08-25

Unknown Phase

Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population

WithdrawnNCT07211204

Timser SAPI de CVAGUS, ASC-US, Atypical Glandular Cells of Uncertain Significance +6

Start: 2026-02-27End: 2026-02-27Updated: 2026-03-03

Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer

RecruitingNCT07480902

Timser SAPI de CVI) Atypical Squamous Cells of Undetermined Significance (ASC-US), II) Atypical Glandular Cells of Uncertain Significance (AGUS), III) Cervical Intraepithelial Neoplasia (CIN), CIN-1, CIN-2, CIN-3 +3

Start: 2026-02-03End: 2026-06-01Target: 558Updated: 2026-03-18

Related Papers

Anti-EGFR Rechallenge in Patients With Refractory ctDNA <i>RAS/BRAF</i> wt Metastatic Colorectal Cancer

JAMA Network Open2024-04-0937 citations

Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial

Nature Medicine2022-08-01235 citations

Circulating Tumor DNA in Identifying Resistant Sub-Clones Post EGFR Blockade: Implications for EGFR Rechallenge

Frontiers in Oncology2022-06-285 citations

Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials.

2018-07-1727 citations

Abstract A089: Exploiting clonal evolution and liquid biopsy to overcome resistance to anti-EGFR treatment in metastatic colorectal cancer: the CHRONOS trial

Molecular Cancer Therapeutics2018-01-019 citations

Abstract A087: Empowering precision medicine in metastatic colorectal cancer: preliminary results from the FUNNEL platform

Molecular Cancer Therapeutics2018-01-01